CXI HEALTHCARE TECHNOLOGY GROUP LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101 KRW | 0.00% |
|
-2.88% | -14.41% |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 54,650 | 46,811 | 25,724 | 37,709 | 31,491 | 26,536 |
| Enterprise Value (EV) 1 | -320,511 | -270,531 | -186,144 | 12,777 | -33,913 | -67,121 |
| P/E ratio | -0.74 x | -0.65 x | -0.26 x | 7.05 x | 5.33 x | 3.45 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.38 x | 0.36 x | 0.41 x | 0.36 x | 0.31 x | 0.37 x |
| EV / Revenue | -2.21 x | -2.09 x | -2.94 x | 0.12 x | -0.33 x | -0.94 x |
| EV / EBITDA | 4.29 x | 3.78 x | 3.88 x | 0.55 x | -1.06 x | -2.16 x |
| EV / FCF | 7.49 x | 6.8 x | 2.43 x | -0.06 x | -1.12 x | -2.26 x |
| FCF Yield | 13.4% | 14.7% | 41.2% | -1,552% | -89.6% | -44.2% |
| Price to Book | 0.1 x | 0.1 x | 0.07 x | 0.1 x | 0.08 x | 0.07 x |
| Nbr of stocks (in thousands) | 110,404 | 110,404 | 110,404 | 116,746 | 123,012 | 165,851 |
| Reference price 2 | 495.0 | 424.0 | 233.0 | 323.0 | 256.0 | 160.0 |
| Announcement Date | 29/10/18 | 08/10/19 | 28/10/20 | 27/10/21 | 18/10/22 | 12/10/23 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 145,264 | 129,309 | 63,406 | 104,593 | 101,376 | 71,617 |
| EBITDA 1 | -74,787 | -71,513 | -47,994 | 23,198 | 32,004 | 31,116 |
| EBIT 1 | -76,497 | -72,894 | -61,950 | 4,529 | 6,292 | 7,136 |
| Operating Margin | -52.66% | -56.37% | -97.7% | 4.33% | 6.21% | 9.96% |
| Earnings before Tax (EBT) 1 | -74,241 | -70,657 | -98,607 | 5,086 | 5,981 | 7,528 |
| Net income 1 | -73,933 | -70,621 | -98,437 | 5,098 | 5,981 | 7,528 |
| Net margin | -50.9% | -54.61% | -155.25% | 4.87% | 5.9% | 10.51% |
| EPS 2 | -670.0 | -648.7 | -891.6 | 45.82 | 48.00 | 46.38 |
| Free Cash Flow 1 | -42,792 | -39,787 | -76,690 | -198,312 | 30,374 | 29,692 |
| FCF margin | -29.46% | -30.77% | -120.95% | -189.6% | 29.96% | 41.46% |
| FCF Conversion (EBITDA) | - | - | - | - | 94.91% | 95.42% |
| FCF Conversion (Net income) | - | - | - | - | 507.8% | 394.43% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 29/10/18 | 08/10/19 | 28/10/20 | 27/10/21 | 18/10/22 | 12/10/23 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 375,161 | 317,343 | 211,868 | 24,932 | 65,404 | 93,657 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -42,792 | -39,787 | -76,690 | -198,312 | 30,374 | 29,692 |
| ROE (net income / shareholders' equity) | -13.3% | -14.6% | -24.6% | 1.4% | 1.51% | 1.81% |
| ROA (Net income/ Total Assets) | -8.2% | -8.84% | -9.31% | 0.76% | 0.97% | 1.06% |
| Assets 1 | 901,816 | 799,073 | 1,057,477 | 672,294 | 618,106 | 712,193 |
| Book Value Per Share 2 | 4,744 | 4,053 | 3,201 | 3,187 | 3,406 | 2,393 |
| Cash Flow per Share 2 | 1,871 | 1,518 | 1,942 | 221.0 | 534.0 | 549.0 |
| Capex | - | 40.9 | 65,700 | 204,888 | 5.78 | - |
| Capex / Sales | - | 0.03% | 103.62% | 195.89% | 0.01% | - |
| Announcement Date | 29/10/18 | 08/10/19 | 28/10/20 | 27/10/21 | 18/10/22 | 12/10/23 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -14.41% | 21M | |
| +12.97% | 8.1B | |
| +3.37% | 7.57B | |
| -15.13% | 5B | |
| -9.87% | 3.57B | |
| -19.61% | 3.2B | |
| -12.98% | 1.19B | |
| -30.67% | 1.06B | |
| -10.43% | 861M | |
| -4.54% | 820M |
- Stock Market
- Equities
- A900120 Stock
- Financials CXI Healthcare Technology Group Limited
